CSPN

Cerep is a leading contract research organization (CRO) and biotechnology company that provides drug discovery and development services to the pharmaceutical industry. The company specializes in high-throughput screening, in vitro pharmacology, and ADME-Tox (Absorption, Distribution, Metabolism, Excretion, and Toxicity) profiling. Cerep is well-known for its proprietary BioPrint database, which integrates pharmacological and clinical data to predict the clinical profiles of new drug candidates. By offering a comprehensive suite of profiling services, Cerep helps pharmaceutical companies identify potential safety issues and optimize drug candidates early in the development process. In 2013, the company was acquired by Eurofins Scientific, further expanding its global reach and service capabilities.